His passion for neuroimmunology led him to a three-year fellowship at Johns Hopkins, focusing on Multiple Sclerosis (MS) clinical care and research, supported by a Sylvia Lawry Physician ...

July 4, 2024 — Researchers have discovered several rare types of helper T cells ... Potential New Drug Treatment for Multiple Sclerosis Dec. 8, 2023 — Pre-clinical studies using a small ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

For over a decade, smaller clinical trials have explored the safety ... people with MS. Neural stem cells are derived from other types of stem cells and can form cells in the central nervous ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which ... you will experience periods of remission with no clinical evidence of disease progression.

Among the total systemic sclerosis cohort, 14% of individuals were categorized as frail and 53% as prefrail, with frailty status linked to an increased risk for mortality.

Findings show accumulation of neuronal injury and functional decline suggesting that changes in gonadal hormones may be associated with changes in functional and biological markers in MS.

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the onset of MS symptoms. Women with multiple sclerosis (MS) show increased risk ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

with an initial focus on multiple sclerosis (MS). Demyelination in MS occurs when the immune system attacks and damages the myelin sheaths that insulate and nourish axons and nerve fibers in the ...

These are just a few of the more common side effects reported by people who used Rebif in clinical trials ... to treat certain forms of multiple sclerosis (MS) in adults. However, the active ...